Tag: Prescription Drugs
No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients
No significant association seen between immunosuppression receipt and incident cancer after adjustment for confounders
ENDO: Teprotumumab Shows Long-Term Efficacy for Thyroid Eye Disease
Inflammatory and ophthalmic composite outcome improvements seen in 90 percent of patients at 72 weeks
Several Drugs Linked to Risk for Aneurysmal Subarachnoid Hemorrhage
aSAH risk increased in association with current use of warfarin, venlafaxine, prochlorperazine, and co-codamol
Smoking Cessation Aids Equally Effective in Those With Mental Health Conditions
Specifically, vaping products, varenicline, and heated tobacco products tied to significantly greater odds of successful cessation
ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung Cancer
Significantly longer progression-free survival, but not overall survival, seen for osimertinib in unresectable EGFR-mutation NSCLC
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia
More patients receiving asciminib than investigator-selected tyrosine kinase inhibitor had major molecular response at 48 weeks
Racial Disparity Seen in Naloxone Administration
Finding seen among Black people with overdose deaths in Pennsylvania versus White people
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema
Ruxolitinib cream well tolerated, and disease control maintained over a year with as-needed use
Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa
Rapid clinically meaningful response seen, which was maintained for 48 weeks for moderate-to-severe hidradenitis suppurativa
